Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference.
Lustig M, Kowol M, Hartmann AM, van der Peet IC, Jansen MJH, Iben K, Winterberg D, Krohn S, Baumann N, Rösner T, Bendig S, Hahn C, Wurm AA, Gehlert CL, Denker M, Suwanchaikasem P, Macarrón Palacios A, Schwartz S, Brüggemann M, Burger R, Schmitt K, Klausz K, Valerius O, Stölzel F, Bastian L, Baldus CD, Peipp M, Leusen JHW, Schewe DM, Valerius T.
Lustig M, et al. Among authors: valerius o.
Blood Neoplasia. 2026 May 5;3(3):100242. doi: 10.1016/j.bneo.2026.100242. eCollection 2026 Aug.
Blood Neoplasia. 2026.
PMID: 42327600
Free PMC article.